Group One Trading
ABEO icon

Group One Trading’s Abeona Therapeutics ABEO Stock Holding History

Group One Trading’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.93K Sell
1,100
-232,400
-100% -$1.16M ﹤0.01% 6721
2025
Q4 		$1.23M Buy
233,500
+182,000
+353% +$916K ﹤0.01% 2708
2025
Q3 		$272K Sell
51,500
-128,400
-71% -$814K ﹤0.01% 4333
2025
Q2 		$1.02M Buy
+179,900
New +$1.02M ﹤0.01% 2741
2024
Q1 		– Sell
-4,100
Closed -$20.5K – 6918
2023
Q4 		$20.5K Buy
+4,100
New +$18K ﹤0.01% 5740
2021
Q3 		– Sell
-824
Closed -$32K – 8084
2021
Q2 		$32K Sell
824
-1,848
-69% -$75.4K ﹤0.01% 6906
2021
Q1 		$126K Buy
+2,672
New +$147K ﹤0.01% 5437
2020
Q3 		– Sell
-20
Closed -$1K – 6009
2020
Q2 		$1K Sell
20
-40
-67% -$2.77K ﹤0.01% 5617
2020
Q1 		$3K Sell
60
-736
-92% -$49.2K ﹤0.01% 4865
2019
Q4 		$65K Buy
796
+604
+315% +$42.6K ﹤0.01% 3880
2019
Q3 		$11K Sell
192
-888
-82% -$66.5K ﹤0.01% 4557
2019
Q2 		$129K Sell
1,080
-48
-4% -$8.05K ﹤0.01% 3155
2019
Q1 		$208K Sell
1,128
-616
-35% -$110K ﹤0.01% 2664
2018
Q4 		$311K Buy
1,744
+552
+46% +$120K ﹤0.01% 2335
2018
Q3 		$381K Buy
1,192
+144
+14% +$51.1K ﹤0.01% 2508
2018
Q2 		$419K Buy
1,048
+76
+8% +$33.2K ﹤0.01% 2439
2018
Q1 		$349K Sell
972
-1,180
-55% -$438K ﹤0.01% 2334
2017
Q4 		$853K Buy
2,152
+912
+74% +$377K 0.01% 1846
2017
Q3 		$529K Buy
+1,240
New +$333K ﹤0.01% 2016
2015
Q4 		– Sell
-232
Closed -$23K – 4683
2015
Q3 		$23K Hold
232
– – ﹤0.01% 3967
2015
Q2 		$29K Buy
+232
New +$34.8K ﹤0.01% 3849

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's ABEO Position: Q1 2026 in Review

Group One Trading reduced its Abeona Therapeutics (ABEO) stake by 35% in Q1 2026, selling an estimated $572K and leaving 209,607 shares worth $939K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

Group One Trading first reported a position in ABEO in Q3 2015 and has held it in 26 quarters since. The position peaked at $1.81M in Q3 2017. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Group One Trading held 209,607 shares of Abeona Therapeutics worth $939K as of Q1 2026.
  • Group One Trading sold 114,379 Abeona Therapeutics shares in Q1 2026, an estimated $572K.
  • Abeona Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2788 holding.
  • Group One Trading first reported a position in Abeona Therapeutics in Q3 2015 and has held it in 26 quarters since.
  • Group One Trading's Abeona Therapeutics position peaked at $1.81M in Q3 2017.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.